Oportuzumab Antibody is a research-grade biosimilar monoclonal antibody targeting CD326. Format: scFv-kappa-heavy (humanized host). Reactivity: Human. Supplied as a liquid in 30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Epithelial cell adhesion molecule (CD326/EPCAM) is a ~34 kDa protein. May act as a physical homophilic interaction molecule between intestinal epithelial cells (IECs) and intraepithelial lymphocytes (IELs) at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection. Plays a role in embryonic stem cells proliferation and differentiation. Up-regulates the expression of FABP5, MYC and cyclins A and E.
